Welltower (WELL) Projected to Release Earnings on Monday

Key Points

• Welltower is expected to report Q3 2026 results after Monday’s market close. Analysts project earnings of $0.645 per share and revenue of $3.66 billion; the earnings call is scheduled for Tuesday, October 27, at 9:00 a.m. ET.
• The healthcare-focused REIT’s previous quarter missed EPS estimates but exceeded revenue expectations, with revenue rising 39.1% year over year to $3.54 billion.
• Analyst sentiment remains favorable: Welltower has a “Moderate Buy” consensus rating and a $255.76 average price target, while the company recently raised its quarterly dividend to $0.85 per share.

Welltower (NYSE:WELL - Get Free Report) is expected to be issuing its Q3 2026 results after the market closes on Monday, October 26th. Analysts expect the company to announce earnings of $0.6450 per share and revenue of $3.66 billion for the quarter. Welltower has set its FY 2026 guidance at 6.360-6.440 EPS. Individuals may review the information on the company's upcoming Q3 2026 earnings report page for the latest details on the call scheduled for Tuesday, October 27, 2026 at 9:00 AM ET.

Welltower (NYSE:WELL - Get Free Report) last announced its earnings results on Monday, July 27th. The real estate investment trust reported $0.61 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.66 by ($0.05). Welltower had a net margin of 12.15% and a return on equity of 3.56%. The firm had revenue of $3.54 billion during the quarter, compared to analyst estimates of $3.40 billion. During the same period in the prior year, the business posted $1.28 EPS. The firm's quarterly revenue was up 39.1% compared to the same quarter last year. On average, analysts expect Welltower to post $6.43 EPS for the current fiscal year and $7.48 EPS for the next fiscal year.

Welltower Trading Up 0.0%

NYSE:WELL opened at $234.91 on Monday. Welltower has a twelve month low of $172.50 and a twelve month high of $255.20. The company has a quick ratio of 3.16, a current ratio of 3.16 and a debt-to-equity ratio of 0.37. The business has a 50 day moving average price of $233.50 and a two-hundred day moving average price of $224.28. The company has a market cap of $169.31 billion, a P/E ratio of 107.75, a price-to-earnings-growth ratio of 1.12 and a beta of 0.75.

Welltower Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, August 20th. Shareholders of record on Wednesday, August 12th were paid a $0.85 dividend. This is a positive change from Welltower's previous quarterly dividend of $0.74. This represents a $3.40 dividend on an annualized basis and a yield of 1.4%. The ex-dividend date was Wednesday, August 12th. Welltower's dividend payout ratio is 155.96%.

Insider Activity

In other Welltower news, Director Andrew Gundlach bought 5,000 shares of Welltower stock in a transaction dated Wednesday, August 26th. The stock was bought at an average cost of $242.06 per share, for a total transaction of $1,210,300.00. Following the purchase, the director owned 30,000 shares of the company's stock, valued at $7,261,800. The trade was a 20.00% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Purchased indirectly through two trusts. The transaction was executed in multiple trades at prices ranging from $241.59 to $242.59. The reported $242.06 price is the weighted-average purchase price. 0.37% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on WELL shares. Weiss Ratings upgraded shares of Welltower from a "hold (c+)" rating to a "buy (b-)" rating in a report on Thursday, October 8th. Scotiabank increased their price target on shares of Welltower from $244.00 to $251.00 and gave the company an "outperform" rating in a research note on Wednesday, September 2nd. Wells Fargo & Company lifted their price objective on shares of Welltower from $237.00 to $266.00 and gave the company an "overweight" rating in a research report on Tuesday, September 1st. BMO Capital Markets lifted their price objective on shares of Welltower from $245.00 to $265.00 and gave the company an "outperform" rating in a research report on Monday, August 3rd. Finally, Deutsche Bank Aktiengesellschaft boosted their price objective on shares of Welltower from $215.00 to $265.00 and gave the stock a "buy" rating in a research note on Wednesday, July 1st. Two research analysts have rated the stock with a Strong Buy rating, fifteen have given a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $255.76.

Welltower Company Profile

Welltower Inc NYSE: WELL is a healthcare-focused real estate investment trust that owns, develops, and manages properties used to provide healthcare and related services. Its portfolio is centered on senior housing communities, outpatient medical facilities, and post-acute care properties, including assets operated by healthcare providers and senior living companies.

The company's senior housing investments support independent living, assisted living, and memory care services. Its outpatient medical properties accommodate physicians, clinics, and other healthcare providers, while its broader healthcare real estate portfolio is designed to serve demand for care delivered outside traditional hospitals.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.